Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The ras oncogene product p21 is not a regulatory component of adenylate cyclase

Abstract

Harvey (Ha-MSV) and Kirsten (Ki-MSV) murine sarcoma viruses induce tumours in animals and transform various cells in culture because of the expression of the ras oncogene product, p21 (ref. 1). Proto-oncogenes homologous with these genes are highly conserved evolutionarily2 and activated ras oncogenes have been detected in many human cancers3–7. Whether c-ras oncogenes are directly responsible for human carcinogenesis is uncertain; however, it is clear that p21 mediates virus-induced transformation, although by an unknown mechanism. Epithelial and fibroblast cell lines transformed with Ha-MSV and Ki-MSV express p21 (ref. 8) and exhibit reduced adenylate cyclase activity9,10. Like the guanine nucleotide regulatory proteins, Ns and Ni, which mediate stimulation11 and inhibition12, respectively, of adenylate cyclase, p21 is a membrane-associated GTP binding protein, which exhibits GTPase activity13–15. These similarities suggest that p21 and the adenylate cyclase regulatory proteins are related in cellular function, and that p21 depresses adenylate cyclase by inhibiting the activity of Ns or acting as Ni. We have therefore now examined the structural and functional similarities between p21 and Ns and Ni and find no evidence that p21 regulates adenylate cyclase activity by acting as one of these regulatory proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shih, T. Y., Weeks, M. O., Young, H. A. & Scolnick, E. M. J. Virol. 31, 546–556 (1979).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Chang, E. H., Gonda, M. A., Ellis, R. W., Scolnick, E. M. & Lowy, D. R. Proc. natn. Acad. Sci. U.S.A. 79, 4848–4852 (1982).

    Article  ADS  CAS  Google Scholar 

  3. Yuasa, Y. et al. Proc. natn. Acad. Sci. U.S.A. 81, 3670–3674 (1984).

    Article  ADS  CAS  Google Scholar 

  4. Shih, T. Y. & Weeks, M. O. Cancer Invest. 2, 109–123 (1984).

    Article  CAS  Google Scholar 

  5. Shimizu, K. et al. Nature 304, 497–500 (1983).

    Article  ADS  CAS  Google Scholar 

  6. Tabin, C. J. et al. Nature 300, 143–152 (1982).

    Article  ADS  CAS  Google Scholar 

  7. Capon, D. J. et al. Nature 304, 507–513 (1983).

    Article  ADS  CAS  Google Scholar 

  8. Willingham, M. C., Pastan, I., Shih, T. Y. & Scolnick, E. M. Cell 19, 1005–1014 (1980).

    Article  CAS  Google Scholar 

  9. Beckner, S. K. FEBS Lett. 166, 170–174 (1984).

    Article  CAS  Google Scholar 

  10. Andersen, W. B. & Pastan, I. Adv. Cyclic Nucleotide Res. 5, 681–697 (1975).

    Google Scholar 

  11. Northup, J. K., Smigel, M. D., Sternweis, P. C. & Gilman, A. G. J. biol Chem. 258, 11369–11376 (1983).

    CAS  PubMed  Google Scholar 

  12. Katada, T., Bokoch, G. M., Northup, J. K., Ui, M. & Gilman, A. G. J. biol. Chem. 259, 3568–3577 (1984).

    CAS  PubMed  Google Scholar 

  13. Shih, T. Y., Papageorge, A. G., Stokes, P. E., Weeks, M. O. & Scolnick, E. M. Nature 287, 686–691 (1980).

    Article  ADS  CAS  Google Scholar 

  14. Gibbs, J. B., Sigal, I. S., Poe, M. & Scolnick, E. M. Proc. natn. Acad. Sci. U.S.A. 81, 5704–5708 (1984).

    Article  ADS  CAS  Google Scholar 

  15. Sweet, R. W. et al. Nature 311, 273–275 (1984).

    Article  ADS  CAS  Google Scholar 

  16. Hattori, S., Ulsh, L. S., Halliday, K. & Shih, T. Y. Molec. cell. Biol. 5, 1449–1455 (1985).

    Article  CAS  Google Scholar 

  17. Hurley, J. B., Simon, M. I., Teplow, D. B., Robishaw, A.J.D. & Gilman, A. G. Science 226, 860–863 (1984).

    Article  ADS  CAS  Google Scholar 

  18. Shih, T. Y. et al. J. Virol. 42, 253–261 (1982).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Furth, M. E., Davis, L. J., Fleurdelys, B. & Scolnick, E. M. J. Virol. 43, 294–304 (1982).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Sternweis, P. C. & Gilman, A. G. J. biol Chem. 254, 3333–3338 (1981).

    Google Scholar 

  21. Sefton, B. M., Trowbridge, I. S., Cooper, J. A. & Scolnick, E. M. Cell 31, 465–474 (1982).

    Article  CAS  Google Scholar 

  22. Bokoch, G. M., Katada, T., Northup, J. K., Ui, M. & Gilman, A. G. J. biol. Chem. 259, 3560–3607 (1984).

    CAS  PubMed  Google Scholar 

  23. Todo, Y. et al. Cell 40, 27–36 (1985).

    Article  Google Scholar 

  24. Gilman, A. G. Cell 36, 577–579 (1984).

    Article  CAS  Google Scholar 

  25. Lochrie, M. A., Hurley, J. B. & Simon, M. I. Science 228, 96–99 (1985).

    Article  ADS  CAS  Google Scholar 

  26. Kahn, R. A. & Gilman, A. G. J. biol. Chem. 259, 6228–6234 (1984).

    CAS  PubMed  Google Scholar 

  27. Northup, J. K., Sternweis, P. C. & Gilman, A. G. J. biol. Chem. 258, 11361–11368 (1983).

    CAS  PubMed  Google Scholar 

  28. James, R. & Bradshaw, R. A. A. Rev. Biochem. 53, 259–301 (1984).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beckner, S., Hattori, S. & Shih, T. The ras oncogene product p21 is not a regulatory component of adenylate cyclase. Nature 317, 71–72 (1985). https://doi.org/10.1038/317071a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/317071a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing